Simultaneous Kinase Inhibition with Ibrutinib and BCL2 Inhibition with Venetoclax As a Therapeutic Strategy for Acute Lymphoblastic Leukemia

被引：0
|
作者：
Eide, Christopher A. [1 ,2 ]
Kurtz, Stephen E. [1 ]
Kaempf, Andy [3 ]
Long, Nicola [1 ]
Leonard, Jessica [1 ]
Chang, Bill H. [4 ]
Mori, Motomi [3 ,5 ]
Druker, Brian J. [1 ,2 ]
Tyner, Jeffrey W. [1 ,6 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA
[2] Howard Hughes Med Inst, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Biostat Shared Resource, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Pediat Hematol & Oncol, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland State Univ, Portland, OR 97201 USA
[6] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131288
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3950
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia
    Christopher A. Eide
    Stephen E. Kurtz
    Andy Kaempf
    Nicola Long
    Anupriya Agarwal
    Cristina E. Tognon
    Motomi Mori
    Brian J. Druker
    Bill H. Chang
    Alexey V. Danilov
    Jeffrey W. Tyner
    Leukemia, 2020, 34 : 2342 - 2353
  • [2] Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia
    Eide, Christopher A.
    Kurtz, Stephen E.
    Kaempf, Andy
    Long, Nicola
    Agarwal, Anupriya
    Tognon, Cristina E.
    Mori, Motomi
    Druker, Brian J.
    Chang, Bill H.
    Danilov, Alexey V.
    Tyner, Jeffrey W.
    LEUKEMIA, 2020, 34 (09) : 2342 - 2353
  • [3] ABT-199 MEDIATED INHIBITION OF BCL2 AS A NOVEL THERAPEUTIC STRATEGY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Peirs, S.
    Matthijssens, F.
    Goossens, S.
    De Bock, C.
    Cante-Barrett, K.
    Lammens, T.
    Van de Walle, I.
    De Moerloose, B.
    Benoit, Y.
    Poppe, B.
    Taghon, T.
    Cools, J.
    Meijerink, J.
    Soulier, J.
    Speleman, F.
    Van Vlierberghe, P.
    HAEMATOLOGICA, 2014, 99 : 539 - 540
  • [4] BCL2 Inhibition by Venetoclax: Targeting the Achilles' Heel of the Acute Myeloid Leukemia Stem Cell?
    Pullarkat, Vinod A.
    Newman, Edward M.
    CANCER DISCOVERY, 2016, 6 (10) : 1082 - 1083
  • [5] Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia
    Ogana, Heather A.
    Hurwitz, Samantha
    Hsieh, Chih-Lin
    Geng, Huimin
    Muschen, Markus
    Bhojwani, Deepa
    Wolf, Mark A.
    Larocque, James
    Lieber, Michael R.
    Kim, Yong Mi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [6] Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia
    Kurtz, Stephen E.
    Eide, Christopher A.
    Kaempf, Andy
    Mori, Motomi
    Tognon, Cristina E.
    Borate, Uma
    Druker, Brian J.
    Tyner, Jeffrey W.
    LEUKEMIA, 2018, 32 (09) : 2025 - 2028
  • [7] Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia
    Stephen E. Kurtz
    Christopher A. Eide
    Andy Kaempf
    Motomi Mori
    Cristina E. Tognon
    Uma Borate
    Brian J. Druker
    Jeffrey W. Tyner
    Leukemia, 2018, 32 : 2025 - 2028
  • [8] Dual Inhibition of Bruton's Tyrosine Kinase and BCL2: A Promising Therapeutic Strategy for Myeloid and Lymphoid Leukemias
    Eide, Christopher A.
    Kurtz, Stephen E.
    Kaempf, Andy
    Tognon, Cristina E.
    Mori, Motomi
    Gordon, Max J.
    Tyner, Jeffrey W.
    Danilov, Alexey V.
    Druker, Brian J.
    BLOOD, 2018, 132
  • [9] ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
    Peirs, Sofie
    Matthijssens, Filip
    Goossens, Steven
    Van de Walle, Inge
    Ruggero, Katia
    de Bock, Charles E.
    Degryse, Sandrine
    Cante-Barrett, Kirsten
    Briot, Delphine
    Clappier, Emmanuelle
    Lammens, Tim
    De Moerloose, Barbara
    Benoit, Yves
    Poppe, Bruce
    Meijerink, Jules P.
    Cools, Jan
    Soulier, Jean
    Rabbitts, Terence H.
    Taghon, Tom
    Speleman, Frank
    Van Vlierberghe, Pieter
    BLOOD, 2014, 124 (25) : 3738 - 3747
  • [10] Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia
    Wang, Xiangmeng
    Mak, Po Yee
    Mu, Hong
    Tao, Wenjing
    Rao, Arvind
    Visweswaran, Ravikumar
    Ruvolo, Vivian
    Pachter, Jonathan A.
    Weaver, David T.
    Andreeff, Michael
    Xu, Bing
    Carter, Bing Z.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (08) : 1636 - 1648
12345